share_log

三生製藥:三生製藥自願公告-三生制药與基石藥業就抗PD-1單抗Nofazinlimab達成許可協議

3SBIO: VOLUNTARY ANNOUNCEMENT OF 3SBIO INC. -3SBIO INC.HAS ENTERED INTO LICENSING AGREEMENT WITH CSTONE PHARMACEUTICALS IN RESPECT OF ANTI-PD-1 MONOCLONAL ANTIBODY NOFAZINLIMAB

香港交易所 ·  Nov 1, 2023 06:12
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more